A detailed history of Iht Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Iht Wealth Management, LLC holds 2,064 shares of VRTX stock, worth $1.04 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,064
Previous 2,115 2.41%
Holding current value
$1.04 Million
Previous $884,000 9.39%
% of portfolio
0.04%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $20,033 - $24,762
-51 Reduced 2.41%
2,064 $967,000
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $137,391 - $150,328
337 Added 18.95%
2,115 $884,000
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $12,348 - $14,784
36 Added 2.07%
1,778 $723,000
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $20,290 - $21,747
-60 Reduced 3.33%
1,742 $605,000
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $44,333 - $49,619
-141 Reduced 7.26%
1,802 $634,000
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $19,826 - $22,617
-70 Reduced 3.48%
1,943 $612,000
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $60,581 - $68,153
-212 Reduced 9.53%
2,013 $581,000
Q3 2022

Nov 22, 2022

BUY
$273.83 - $305.53 $609,271 - $679,804
2,225 New
2,225 $644,000
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $431,856 - $537,706
-1,838 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $537,607 - $633,635
-2,428 Reduced 56.92%
1,838 $480,000
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $92,399 - $116,640
-522 Reduced 10.9%
4,266 $937,000
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $264,648 - $296,162
-1,459 Reduced 23.36%
4,788 $868,000
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $116,056 - $136,860
619 Added 11.0%
6,247 $1.26 Million
Q1 2021

May 18, 2021

BUY
$207.02 - $241.31 $115,103 - $134,168
556 Added 10.96%
5,628 $1.21 Million
Q4 2020

Feb 17, 2021

BUY
$207.01 - $276.09 $502,827 - $670,622
2,429 Added 91.9%
5,072 $1.2 Million
Q3 2020

Nov 19, 2020

SELL
$255.65 - $303.1 $464,516 - $550,732
-1,817 Reduced 40.74%
2,643 $719,000
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $480,046 - $629,758
2,129 Added 91.33%
4,460 $1.3 Million
Q1 2020

May 13, 2020

BUY
$199.77 - $247.81 $231,333 - $286,963
1,158 Added 98.72%
2,331 $555,000
Q4 2019

Feb 18, 2020

SELL
$166.71 - $223.91 $36,509 - $49,036
-219 Reduced 15.73%
1,173 $257,000
Q3 2019

Nov 15, 2019

BUY
$166.23 - $187.09 $33,578 - $37,792
202 Added 16.97%
1,392 $236,000
Q2 2019

Aug 12, 2019

BUY
$164.61 - $190.37 $195,885 - $226,540
1,190 New
1,190 $218,000
Q2 2018

Aug 13, 2018

SELL
$145.72 - $169.96 $17,049 - $19,885
-117 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $10,982 - $12,444
80 Added 216.22%
117 $18,000
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $5,480 - $6,002
37
37 $6,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Iht Wealth Management, LLC Portfolio

Follow Iht Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.